Johnson & Johnson is appealing two recent jury verdicts awarding a total of $127 million to women who blame their ovarian cancer on talc in the company’s iconic baby powder.

The monetary awards have raised the specter that women’s use of talcum powder may be to blame for some cases of ovarian cancer, though research into a possible link has returned mixed results and those studies finding a link showed only a slightly higher risk of the cancer.

“Unfortunately, the jury’s decision goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc,” J&J said in a statement, responding to the latest verdict on Monday.

In that case, a jury in St. Louis awarded $55 million to Gloria Ristesund, who was diagnosed with ovarian cancer in 2011. In the same court in February, a jury awarded $72 million to the family of Jacqueline Fox, an Alabama woman who died from ovarian cancer.

Another jury, considering a talc lawsuit in a South Dakota federal court, decided in 2013 that J&J was negligent but didn't award damages.